Location History:
- Indianapolis, IN (US) (2000 - 2005)
- Carmel, IN (US) (2006 - 2007)
Company Filing History:
Years Active: 2000-2007
Title: Innovations by Michael Rosario DeFelippis
Introduction
Michael Rosario DeFelippis is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations that combine GLP-1 polypeptides and insulin. With a total of 7 patents to his name, DeFelippis continues to push the boundaries of medical science.
Latest Patents
Among his latest patents are two groundbreaking inventions. The first is a formulation that encompasses pre-mixed formulations comprising a GLP-1 polypeptide and a basal insulin. This invention aims to improve the efficacy and convenience of diabetes treatment. The second patent involves biphasic mixtures of GLP-1 and insulin, which includes pharmaceutical formulations that consist of a glucagon-like peptide (GLP-1) compound in a solid phase and insulin in a solution phase. These innovations represent a significant advancement in diabetes management.
Career Highlights
DeFelippis is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to medical science.
Collaborations
Some of his notable coworkers include Michael Allen Dobbins and Kingman Ng. Their collaborative efforts have played a crucial role in the development of new pharmaceutical solutions.
Conclusion
Michael Rosario DeFelippis is a distinguished inventor whose work has significantly impacted the field of diabetes treatment. His innovative patents and collaborations continue to pave the way for advancements in healthcare.